Last Modified: February 10, 2003
Conference Dates: February 28 - March 1, 2003
Conference Location: Newport Beach, California
Sponsoring Group: Imedex, Inc.
Conference Web Page URL: www.imedex.com/announcements/uroonc03.html
Topics Covered: Diagnosis and Management of Bladder Cancer, Adrenal Tumors, Renal Cell Carcinoma, Testis Cancer, Prostate Cancer, Urology in the 21st Century: Challenges and Opportunities
Conference Objectives: Objectives After successfully completing this educational program, participants should be able to: Recommend the most appropriate techniques for the diagnosis, treatment, and monitoring of superficial bladder cancer, Advise their patients with muscle invasive or metastatic bladder cancer on their treatment options, Discuss the merits of urinary diversion and orthotopic bladder replacement techniques, Discuss the role of observation, surgery, systemic therapy, and combined modality therapy in the management of renal cell carcinoma, Advise patients with upper tract transitional cell carcinoma on their management options, Advise their patients with testicular or adrenal malignancies on their treatment options, Comment on the merits of screening for prostate cancer, Recommend the most appropriate management options for patients with clinically localized, recurrent or advanced prostate cancer, Evaluate methods for the reduction of post-prostat! ectomy incontinence and impotence, Discuss the merits of laparoscopic vs. open surgery for selected urologic surgical procedures.
Who Should Attend: This program is intended for urologists, oncologists, radiation therapists, and other practitioners involved in the diagnosis and management of urologic cancers. No specific knowledge or skills other than a basic training in one of the above-mentioned disciplines is required for successful participation in the program.
Conference Fees: Physicians: $499, $50 group discount. Nurses/Fellows/Residents: $349.
Continuing Education: Yes
Miscellany: 12.5 hours, category 1. Conference Chairman: Andrew C. Novick, M.D., The Cleveland Clinic, Cleveland, Ohio
Jul 30, 2013 - The American Society of Clinical Oncology has updated the 2003 recommendations on tobacco cessation and control; the policy statement has been published online July 29 in the Journal of Clinical Oncology.
May 29, 2014
Feb 25, 2011
Feb 27, 2015